AMPLIRUN® Influenza RNA Control, 50 µl

The amplirun® influenza rna controls provide purified, quantified RNA from Influenza A (H1, H3, H5), Influenza B, and Novel Influenza A (H1N1) for use as positive controls in nucleic acid amplification techniques. Each control contains the complete viral genome, quantified at 12,500–20,000 copies/µL (qPCR-determined), and is supplied in a lyophilized, non-infectious format.

These RNA controls are fully compatible with PCR, qPCR, RT-PCR, and other molecular testing platforms, offering laboratories standardized, reproducible reference material for assay validation, QC, and respiratory virus research.

Available Controls

Key Features

• Purified complete influenza viral RNA – available for Influenza A (H1, H3, H5), Influenza B, and Novel Influenza A (H1N1).
• qPCR quantified – 12,500–20,000 copies/µL.
• Sequencing data available – supports assay design for primers and probes.
• Non-infectious & lyophilized – stable at ambient shipping and storage, safe to handle.
• Easy reconstitution – resuspend with 50 µL Molecular Biology Grade Water (provided).
• Universal compatibility – validated for PCR, qPCR, RT-PCR, and other molecular workflows.

Applications

• Positive controls for Influenza PCR/qPCR and RT-PCR assays.
• Validation of in-house and commercial diagnostic kits.
• Absolute RNA quantification using standard curve methods.
• QC material to ensure sensitivity, specificity, and reproducibility of influenza assays.
• Research into seasonal influenza, pandemic strains, and vaccine development.

Product Details

The amplirun® influenza rna controls provide a reliable and standardized solution for laboratories working on molecular detection of influenza viruses. With quantified viral RNA, sequencing references, and CE IVDR certification, these controls enable accurate assay validation, reproducible QC, and high-quality respiratory virus research. Safe, stable, and reproducible, they are indispensable for influenza diagnostics and epidemiological studies.